PIERIS PHARMACEUTICALS, INC. (PIRS) Operating Margin % [USD] 2013 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Pieris Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2013 to 2023.
  • Pieris Pharmaceuticals, Inc. Operating Margin for the quarter ending March 31, 2024 was -47.8 %, a 84.4% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Operating Margin for 2023 was -69.5 %, a 58.6% increase from 2022.
  • Pieris Pharmaceuticals, Inc. annual Operating Margin for 2022 was -168 %, a 1.74% decline from 2021.
  • Pieris Pharmaceuticals, Inc. annual Operating Margin for 2021 was -165 %, a 42.6% decline from 2020.
Operating Margin, Annual (% [USD])
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -69.5 +98.3 +58.6% Jan 1, 2023 Dec 31, 2023
2022 -168 -2.87 -1.74% Jan 1, 2022 Dec 31, 2022
2021 -165 -49.3 -42.6% Jan 1, 2021 Dec 31, 2021
2020 -116 -57 -97.1% Jan 1, 2020 Dec 31, 2020
2019 -58.7 +47.3 +44.6% Jan 1, 2019 Dec 31, 2019
2018 -106 -48.2 -83.5% Jan 1, 2018 Dec 31, 2018
2017 -57.7 +333 +85.2% Jan 1, 2017 Dec 31, 2017
2016 -390 +76.3 +16.4% Jan 1, 2016 Dec 31, 2016
2015 -467 -332 -248% Jan 1, 2015 Dec 31, 2015
2014 -134 -139 -3111% Jan 1, 2014 Dec 31, 2014
2013 4.46 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.